Is hepatitis B antigen in cord blood an immunotolerogen playing a critical role in the pathogenesis of chronic hepatitis B?

References

• Milich DR. Is the function of the HBeAg really unkonwn? Hum Vaccin Immunother. 2019;in press.
   Google Scholar
• Huang H, Ning M, Liu J, Chen J, Feng J, Dai Y, Hu Y, Zhou YH. Comparison of antibody response to hepatitis B vaccination in infants with positive or negative maternal hepatitis B e antigen (HBeAg) in cord blood: implication for the role of HBeAg as an immunotolerogen. Hum Vaccin Immunother. 2019;1–4. doi:10.1080/21645515.2019.1575712.
   Google Scholar
• Hsu HY, Chang MH, Hsieh RP, Ni YH, Chi WK. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hepatology. 1996;24(6):1355–60. doi:10.1002/hep.510240607.
   PubMed Web of Science ®Google Scholar
• Böcher WO, Herzog-Hauff S, Schlaak J, Meyer Zum Büschenfeld KH, Löhr HF. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. Hepatology. 1999;29(1):238–44. doi:10.1002/hep.510290120.
   PubMed Web of Science ®Google Scholar
• Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105(2):94–98. doi:10.1093/oxfordjournals.aje.a112370.
   PubMed Web of Science ®Google Scholar
• Nayak NC, Panda SK, Zuckerman AJ, Bhan MK, Guha DK. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol. 1987;21(2):137–45. doi:10.1002/jmv.1890210205.
   PubMed Web of Science ®Google Scholar
• Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99. doi:10.1002/hep.29800.
   PubMed Web of Science ®Google Scholar
• Liu J, Xu B, Chen T, Chen J, Feng J, Xu C, Liu L, Hu Y, Zhou YH. Presence of hepatitis B virus markers in umbilical cord blood: exposure to or infection with the virus? Dig Liver Dis. 2018; pii S1590–8658(18):31222–2. doi:10.1016/j.dld.2018.11.003.
   Google Scholar
• Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A. 1990;87(17):6599–603. doi:10.1073/pnas.87.17.6599.
   PubMed Web of Science ®Google Scholar
• Ou JH, Laub O, Rutter WJ. Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci U S A. 1986;83(6):1578–82. doi:10.1073/pnas.83.6.1578.
   PubMed Web of Science ®Google Scholar
• Standring DN, Ou JH, Masiarz FR, Rutter WJ. A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes. Proc Natl Acad Sci U S A. 1988;85(22):8405–09. doi:10.1073/pnas.85.22.8405.
   PubMed Web of Science ®Google Scholar
• Hsu HY, Chang MH, Hsieh KH, Lee CY, Lin HH, Hwang LH, Chen PJ, Chen DS. Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology. 1992;15(5):770–76. doi:10.1002/hep.1840150505.
   PubMed Web of Science ®Google Scholar
• Reifenberg K, Deutschle T, Wild J, Hanano R, Gastrock-Balitsch I, Schirmbeck R, Schlicht HJ. The hepatitis B virus e antigen cannot pass the murine placenta efficiently and does not induce CTL immune tolerance in H-2b mice in utero. Virology. 1998;243(1):45–53. doi:10.1006/viro.1998.9033.
   PubMed Web of Science ®Google Scholar
• Merkle H, Deutschle T, Gastrock-Balitsch I, Nusser P, Knehr S, Reifenberg K. H-2(d) mice born to and reared by HBeAg-transgenic mothers do not develop T cell tolerance toward the hepatitis B virus core gene products. Virology. 2000;273(1):149–59. doi:10.1006/viro.2000.0391.
   PubMed Web of Science ®Google Scholar
• Hong M, Sandalova E, Low D, Gehring AJ, Fieni S, Amadei B, Urbani S, Chong YS, Guccione E, Bertoletti A. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588. doi:10.1038/ncomms7588.
   PubMed Web of Science ®Google Scholar
• Sun KX, Li J, Zhu FC, Liu JX, Li RC, Zhai XJ, Li YP, Chang ZJ, Nie JJ, Zhuang H. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. Vaccine. 2012;30(36):5335–40. doi:10.1016/j.vaccine.2012.06.036.
   PubMed Web of Science ®Google Scholar
• Wen WH, Chang MH, Zhao LL, Ni YH, Hsu HY, Wu JF, Chen PJ, Chen DS, Chen HL. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol. 2013;59(1):24–30. doi:10.1016/j.jhep.2013.02.015.
   PubMed Web of Science ®Google Scholar
• Liu J, Bi Y, Xu C, Liu L, Xu B, Chen T, Chen J, Pan M, Hu Y, Zhou YH. Kinetic changes of viremia and viral antigens of hepatitis B virus during and after pregnancy. Medicine (Baltimore). 2015;94(45):e2001. doi:10.1097/MD.0000000000002001.
   PubMed Web of Science ®Google Scholar
• Kubo A, Shlager L, Marks AR, Lakritz D, Beaumont C, Gabellini K, Corley DA. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med. 2014;160(12):828–35. doi:10.7326/M13-2529.
   PubMed Web of Science ®Google Scholar
• Schillie S, Walker T, Veselsky S, Crowley S, Dusek C, Lazaroff J, Morris SA, Onye K, Ko S, Fenlon N, et al. Outcomes of infants born to women infected with hepatitis B. Pediatrics. 2015;135(5):e1141–7. doi:10.1542/peds.2014-3213.
   PubMed Web of Science ®Google Scholar
• Cheung KW, Seto MTY, Kan ASY, Wong D, Kou KO, So PL, Lau WL, Jalal K, Chee YY, Wong RMS, et al. Immunoprophylaxis failure of infants born to hepatitis B carrier mothers following routine vaccination. Clin Gastroenterol Hepatol. 2018;16(1):144–45. doi:10.1016/j.cgh.2017.07.013.
   PubMed Web of Science ®Google Scholar
• Hu Y, Xu C, Xu B, Hu L, Liu Q, Chen J, Liu J, Liu L, Yang J, Chen T, et al. Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: A multicenter prospective cohort study. J Viral Hepat. 2018;25(4):429–37. doi:10.1111/jvh.12834.
   PubMed Web of Science ®Google Scholar
• Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324–34. doi:10.1056/NEJMoa1508660.
   PubMed Web of Science ®Google Scholar
• Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, Salvadori N, Cressey TR, Sirirungsi W, Achalapong J, et al. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. N Engl J Med. 2018;378(10):911–23. doi:10.1056/NEJMoa1708131.
   PubMed Web of Science ®Google Scholar
• Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology. 2014;60(2):468–76. doi:10.1002/hep.27034.
   PubMed Web of Science ®Google Scholar
• Bertoletti A, Southwood S, Chesnut R, Sette A, Falco M, Ferrara GB, Penna A, Boni C, Fiaccadori F, Ferrari C. Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18–27: interaction with HLA and T-cell receptor. Hepatology. 1997;26(4):1027–34. doi:10.1002/hep.510260435.
   PubMed Web of Science ®Google Scholar
• Heathcote J, McHutchison J, Lee S, Tong M, Benner K, Minuk G, Wright T, Fikes J, Livingston B, Sette A, et al. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T cell vaccine study group. Hepatology. 1999;30(2):531–36. doi:10.1002/hep.510300208.
   PubMed Web of Science ®Google Scholar
• Hollinger FB, Liang JK. Hepatitis B virus. In: Knipe D, Howley P, Griffin D, editors. Fields virology. 4th. Philadelphia: Lippincott Williams & Wilkins; 2001. p.2971–3036.
   Google Scholar